Our Preclinical Pharmaceutical Sciences group provides a wide range of expertise to help our clients select and progress compounds from lead identification through support of Phase 3 and registration. With integrated capabilities in drug metabolism and pharmacokinetics (DMPK), toxicology and, bioanalytical services we provide timely, accurate, and accessible data.
When you work with RTI Health Solutions you gain access to our experienced team and network of research facilities. We tailor programs to meet our clients’ needs, whether that is to implement specific studies or parts of your preclinical program, or provide consulting support to help you plan and manage your program and develop strategies that optimize the progress of your compounds. As part of our consulting service we develop full preclinical programs, monitor established programs, monitor studies and prepare IND materials for regulatory submission.
Comprehensive selection of in vivo and in vitro DMPK services; standard regulatory-driven study designs and innovative approaches to unique drug development issues.
Toxicology
Development of appropriate biological models to test the safety of your compounds; standard preclinical studies to evaluate the safety of new drug candidates; specialty studies with unique biological models to assess drug efficacy and ensure quick and efficient IND submission.
Bioanalytical Chemistry Services
Support and consultation to major pharmaceutical companies; metabolite identification; clinical trial sample analysis; LC/MS/MS methods development and validation; targeted biomarker platform; DMPK and toxicology support.
